Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Boeing will avoid prosecution over 737 Max crashes under deal
The Justice Department has reached a deal with Boeing that will allow the company to avoid criminal prosecution for allegedly misleading U.S. regulators about the 737 Max jetliner before two of the planes crashed and killed 346 people.
Big Business This Week: Uber über alles
After a bumpy ride, the ride-hailing app is back in the good graces of investors. Plus: OpenAI, Google, Apple, Target, Moody's, Paramount, and Golden Dome.
Nike to start selling its products directly on Amazon’s US website again
Nike is going to start selling its products directly on Amazon’s U.S. website for the first time since 2019.
Everything You Need to Know About Universal Epic Universe
Universal's newest park hosts themed worlds for Super Mario Bros., "How to Train Your Dragon," and more.
This Might Be the Coolest Thing From Google I/O 2025—Here’s Why
Managing Editor at Tom's Guide Kate Kozuch, discusses why the most captivating technology will soon be right in front of your nose, literally.
Report: Smoke filled the cabin of a Delta plane in Atlanta
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Top Travel Tips for Memorial Day Weekend 2025
AAA spokesperson, Aixa Diaz, gives her top tips for the record-breaking travel expected this Memorial Day weekend. Find out what you need to know!
Leading with Integrity: How a Family Brand Became a Pioneer in Organic Food
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Levi Strauss agrees to sell Casual Friday staple Dockers for up to $391 million
Levi Strauss is set to finally part ways with Dockers.
